Mira Pharmaceuticals Inc (MIRA) Company Profile & Statistics

Mira Pharmaceuticals Inc
MIRA
(Nasdaq - US)
Closed
1.31
+0.05 (+3.97%)
in:usd•As of: Nov 22, 2024 15:59 UTC -5
Open
1.23
High
1.33
Low
1.23

About Mira Pharmaceuticals Inc

CEO

Erez Aminov

Headquarters

1200 brickell avenue, suite 1950 #1183

miami, fl 33131, united states

Auditor

Cherry Bekaert LLP

Employees

Share Holders

Website

https://mirapharmaceuticals.com

Industry

pharmaceuticals other

Sector

health technology

Company Overview

MIRA Pharmaceuticals Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. MIRA Pharmaceuticals Inc. is based in Baltimore, Maryland.

Mira Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization ²	21.69M
Enterprise Value	17.55M
Enterprise Value/EBITDA (ttm)	-2.03
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	5.79
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-337.44%
Return on Invested Capital (ttm)	-320.13%
Return on Assets (ttm)	-280.58%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-8.64M
Net Income Avi to Common (ttm)	-11.24M
Diluted EPS (ttm)	-0.56

Share Statistics

Beta (5Y Monthly)	3.09
52-Week Change	-71.83%
S&P500 52-Week Change	30.93%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	16.56M
Dividend Yield	0.00%
Float ⁴	15.46M
% Held by Insiders	6.65%
% Held by Institutions	35.16%

Balance Sheet

Total Cash (mrq)	4.14M
Total Cash Per Share (mrq)	0.25
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	6.11%
Quick Ratio (mrq)	6.11%
Book Value Per Share (mrq)	0.22

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.25
Free Cash Flow (ytd)	-3.76M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Mira Pharmaceuticals Inc

Trade With A Regulated Broker